---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/249858365.md"
description: "The A-share innovative drug concept continues to be strong, with YABAO PHARM.CORP hitting the limit up, and JENKEM, HSGC, YKYY, MEDISAN, HITECK, and others leading in gains"
datetime: "2025-07-24T01:32:04.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/249858365.md)
  - [en](https://longbridge.com/en/news/249858365.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/249858365.md)
---

# 

The A-share innovative drug concept continues to be strong, with YABAO PHARM.CORP hitting the limit up, and JENKEM, HSGC, YKYY, MEDISAN, HITECK, and others leading in gains

### Related Stocks

- [600351.CN](https://longbridge.com/en/quote/600351.CN.md)
- [688356.CN](https://longbridge.com/en/quote/688356.CN.md)
- [600774.CN](https://longbridge.com/en/quote/600774.CN.md)
- [002900.CN](https://longbridge.com/en/quote/002900.CN.md)
- [300683.CN](https://longbridge.com/en/quote/300683.CN.md)
- [688658.CN](https://longbridge.com/en/quote/688658.CN.md)

## Related News & Research

- [Tim Lamb Group Completes Sale of Seven Firelands Automotive Group Dealerships in Northern Ohio](https://longbridge.com/en/news/286806685.md)
- [Microbiotica reports positive results for MB097 in advanced melanoma](https://longbridge.com/en/news/286740265.md)
- [Manulife Singapore to offer multi-cancer blood test starting May](https://longbridge.com/en/news/286710691.md)
- [JP Morgan maintains $6,000 gold target as 2H26 demand seen picking up pace](https://longbridge.com/en/news/286710510.md)
- [20:03 ETHarbour BioMed Announces Promising Preclinical Data for LET003, Its First AI-Enabled Drug Candidate](https://longbridge.com/en/news/286688082.md)